Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis Healthcare...

    Fortis Healthcare appoints Shirish Moreshwar Apte as vice-chairman

    Farhat NasimWritten by Farhat Nasim Published On 2019-01-01T11:03:47+05:30  |  Updated On 1 Jan 2019 11:03 AM IST
    Fortis Healthcare appoints Shirish Moreshwar Apte as vice-chairman

    The board of directors of the company has approved the appointment of Apte as an additional director designated as vice-chairman under the category of 'non-executive non-independent director' with immediate effect, Fortis Healthcare said in a filing to the BSE.


    New Delhi: Fortis Healthcare Monday said it has appointed Shirish Moreshwar Apte as vice-chairman of the company. It has also extended the last date for the acquisition of a portfolio of assets of the Singapore-listed entity RHT Health Trust to March 26, 2019.

    The board of directors of the company has approved the appointment of Apte as an additional director designated as vice-chairman under the category of 'non-executive non-independent director' with immediate effect, Fortis Healthcare said in a filing to the BSE.

    "He will hold the office up to the ensuing annual general meeting and will be regularised, subject to the approval of the shareholders," it added.

    Apte was appointed to the board of IHH Healthcare Berhad in September 2014, Fortis Healthcare said.

    Currently, he is also the independent non-executive chairman of Pierfront Mezzanine Fund Pte. Apte concurrently serves on several boards of directors including Commonwealth Bank of Australia, the Supervisory Board of Bank Handlowy, Poland and Fullerton India Credit Company Ltd, it added.

    Prior to his retirement from Citigroup in 2014 as chairman of Asia Pacific Banking, Apte had built up a 32-year career with Citibank/Citigroup, Fortis Healthcare said.

    The board of directors has also approved the appointment of BSR & Co LLP as the statutory auditors of the company with immediate effect, as its earlier auditors Deloitte Haskins & Sells LLP resigned with effect from December 28, 2018.

    BSR & Co LLP will hold the office till the conclusion of the ensuing annual general meeting subject to the approval of shareholders of the company, Fortis Healthcare said in a filing to the BSE.

    The board of directors have also "approved the extension of the long stop date of December 31, 2018, under the Master Purchase Agreement (MPA) to March 26, 2019, as per mutual agreement, and on the same terms and conditions undertaken for the earlier extension vide amendment agreement dated August 24, 2018. The extension of the long stop date has been accepted and approved by RHT as well," it added.


    Read Also: Fortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers and 7 others: SEBI

    Asia Pacific BankingCommonwealth Bank of AustraliaFHLFortisFortis Healthcarehospital chainsIHH HealthcareMaster Purchase Agreementmpanon-executive non-independent directorPierfront MezzanineRHT Health TrustShirish Moreshwar ApteVCvice chairman
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok